These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24613272)

  • 61. Multiple infections of Trypanosoma brucei gambiense in blood and cerebrospinal fluid of human African trypanosomosis patients from Angola: consequences on clinical course and treatment outcome.
    Truc P; Tiouchichine ML; Cuny G; Vatunga G; Josenando T; Simo G; Herder S
    Infect Genet Evol; 2012 Mar; 12(2):399-402. PubMed ID: 22285307
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [African sleeping sickness in The Netherlands].
    Otte JA; Nouwen JL; Wismans PJ; Beukers R; Vroon HJ; Stuiver PC
    Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2100-4. PubMed ID: 7477570
    [TBL] [Abstract][Full Text] [Related]  

  • 63. How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?
    Büscher P; Deborggraeve S
    Expert Rev Mol Diagn; 2015 May; 15(5):607-15. PubMed ID: 25786994
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.
    Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E
    Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Double trypanosomal chancre revealing West African trypanosomiasis in a Frenchman living in Gabon].
    Hope-Rapp E; Moussa Coulibaly O; Klement E; Danis M; Bricaire F; Caumes E
    Ann Dermatol Venereol; 2009 Apr; 136(4):341-5. PubMed ID: 19361701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Human African trypanosomiasis].
    Dumas M; Bouteille B
    C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human African trypanosomiasis: a review of non-endemic cases in the past 20 years.
    Migchelsen SJ; Büscher P; Hoepelman AI; Schallig HD; Adams ER
    Int J Infect Dis; 2011 Aug; 15(8):e517-24. PubMed ID: 21683638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The evolving spectrum of human African trypanosomiasis.
    Kennedy PGE
    QJM; 2024 Jun; 117(6):391-395. PubMed ID: 38065835
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment options for second-stage gambiense human African trypanosomiasis.
    Eperon G; Balasegaram M; Potet J; Mowbray C; Valverde O; Chappuis F
    Expert Rev Anti Infect Ther; 2014 Nov; 12(11):1407-17. PubMed ID: 25204360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
    Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
    Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Control and surveillance of human African trypanosomiasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2013; (984):1-237. PubMed ID: 24552089
    [TBL] [Abstract][Full Text] [Related]  

  • 72. African sleeping sickness in the United States. Successful treatment with eflornithine.
    Petru AM; Azimi PH; Cummins SK; Sjoerdsma A
    Am J Dis Child; 1988 Feb; 142(2):224-8. PubMed ID: 3124603
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 74. Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.
    Alirol E; Schrumpf D; Amici Heradi J; Riedel A; de Patoul C; Quere M; Chappuis F
    Clin Infect Dis; 2013 Jan; 56(2):195-203. PubMed ID: 23074318
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polysomnography as a diagnosis and post-treatment follow-up tool in human African trypanosomiasis: a case study in an infant.
    Mpandzou G; Cespuglio R; Ngampo S; Bandzouzi B; Bouteille B; Vincendeau P; Buguet A
    J Neurol Sci; 2011 Jun; 305(1-2):112-5. PubMed ID: 21470639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [African trypanosomiasis in children treated with eflornithine. A case].
    Benhamou PH; Chandenier J; Schechter PJ; Epelbaum S; Tell GP; Haegele KD; Pautard JC; Piussan C
    Presse Med; 1989 Jun; 18(24):1199-202. PubMed ID: 2525760
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A returning traveller with fever, facial swelling, and skin lesions.
    Richter J; Göbels S; Göbel T; Westenfeld R; Müller-Stöver I; Häussinger D
    BMJ; 2012 Mar; 344():e2092. PubMed ID: 22442353
    [No Abstract]   [Full Text] [Related]  

  • 78. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire].
    De Groof D; Bruneel H; Musumari TS; Ruppol JF
    Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Cutaneous lesions in human African trypanosomiasis].
    Tatibouet MH; Gentilini M; Brucker G
    Sem Hop; 1982 Nov; 58(40):2318-24. PubMed ID: 6297013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.